The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia.

by Muhammad Rauzan, Charles T H Chuah, Tun Kiat Ko, S Tiong Ong
Published 2017-01-01

A novel Bcr-Abl–mTOR–eIF4A axis regulates IRES-mediated translation of LEF-1

by Becky Pinjou Tsai, Judith Jimenez, Sharon Lim, Kerry D. Fitzgerald, Min Zhang, Charles T. H. Chuah, Haley Axelrod, Luke Nelson, S. Tiong Ong, Bert L. Semler, Marian L. Waterman
Published 2014-01-01